Feb 22, 2023 / 04:00PM GMT
Yigal Dov Nochomovitz - Citigroup Inc., Research Division - Director
All right. Great. Welcome back, everyone. I think everyone knows me. I'm Yigal Nochomovitz, one of the biotech analysts at Citi. This is the second day of Citi's Virtual Oncology Leadership Summit. It's great to have the senior management of ORIC here, Jacob Chacko and Pratik Multani. Thank you both so much for joining. We really appreciate the time.
Questions and Answers:
Yigal Dov Nochomovitz - Citigroup Inc., Research Division - DirectorMaybe, Jacob, if you want to just kick it off with the high-level introduction to ORIC. What's the business strategy? What are you focused on? A little bit on the 3 clinical stage programs that you're running right now? And some of the -- just your thoughts conceptually on how you select targets and your approach to drug development?
Jacob M. Chacko - ORIC Pharmaceuticals, Inc. - President, CEO & Director
Sure thing, Yigal. There's a lot wrapped up in that. Thank you for having us today. We appreciate